首页> 外文期刊>Regulatory Toxicology and Pharmacology: RTP >Approaches for grouping of pesticides into cumulative assessment groups for risk assessment of pesticide residues in food
【24h】

Approaches for grouping of pesticides into cumulative assessment groups for risk assessment of pesticide residues in food

机译:农药分组累积评估群体的方法,用于食品中农药残留量的风险评估

获取原文
获取原文并翻译 | 示例
       

摘要

The European Food Safety Authority (EFSA) is developing approaches to cumulative risk assessment of pesticides by assigning individual pesticides to cumulative assessment groups (CAGs). For assignment to CAGs, EFSA recommended to rely on adverse effects on the specific target system. Contractors to EFSA have proposed to allocate individual pesticides into CAGs relying on NOAELs for effects on target organs. This manuscript evaluates the assignments by applying EFSAs criteria to the CAGs "Toxicity to the nervous system" and "Toxicity to the thyroid hormone system (gland or hormones)". Assignment to the CAG "Toxicity to the nervous system" based, for example, on neurochemical effects like choline esterase inhibition is well supported, whereas assignment to the CAG "Toxicity to the thyroid hormone system (gland or hormones)" has been based in the examined case studies on non-reproducible effects seen in single studies or on observations that are not adverse. Therefore, a more detailed effects evaluation is required to assign a pesticide to a CAG for a target organ where many confounders regarding effects are present. Relative potency factors in cumulative risk assessment should be based on benchmark doses from studies in one species with identical study design and human relevance of effects on specific target organs should be analyzed to define minimal margins of exposure. (C) 2016 The Authors. Published by Elsevier Inc.
机译:欧洲食品安全管理局(EFSA)正在向累积评估群体(CAG)分配个别农药来制定累积风险评估的累积风险评估方法。对于CAG的分配,EFSA建议依靠对特定目标系统的不利影响。 efsa承包商提议将个别农药分配到依托诺雅的CAG对目标器官的影响。本手稿通过将EFSAS标准应用于CAG“对神经系统的毒性”和“甲状腺激素系统(腺体或激素)的毒性”来评估任务。基于胆碱酯酶抑制等神经化学作用的基于神经化学作用的CAG“毒性”分配,而CAG“对甲状腺激素系统(腺体或激素)的分配是基于的检查单一研究中观察到的非可重复效应的案例研究或不逆行的观察结果。因此,需要更详细的效果评估来为目标器官分配给CAG的杀虫剂,其中存在许多关于效果的混淆。累积风险评估中的相对效力因素应基于从一个物种中研究的基准剂量,具有相同的研究设计,应分析对特异性靶器官的影响的人类相关性以定义暴露的最小边缘。 (c)2016年作者。 elsevier公司发布

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号